A prospective evaluation of 73 patients with M0 localized prostate cancer (PCa) found that 68Ga-PSMA-11 PET-CT significantly influenced the intended definitive radiation therapy (RT) planning for PCa. The gene discussed is FOLH1; the disease is posterior cortical atrophy.